vs
Immunovant, Inc.（IMVT）与MIND TECHNOLOGY, INC（MIND）财务数据对比。点击上方公司名可切换其他公司
MIND TECHNOLOGY, INC的季度营收约是Immunovant, Inc.的1.2倍（$9.7M vs $8.4M），MIND TECHNOLOGY, INC净利率更高（0.6% vs -899.0%，领先899.6%），Immunovant, Inc.同比增速更快（140.7% vs -20.0%），MIND TECHNOLOGY, INC自由现金流更多（$801.0K vs $-59.8M）
Immunovant是一家临床阶段生物制药企业，专注于开发用于治疗严重、罕见自身免疫性疾病及炎症性疾病的新型单克隆抗体疗法，其核心在研候选产品覆盖多种自身免疫适应症，面向全球医疗市场布局研发管线。
MIND TECHNOLOGY, INC成立于1987年，总部位于得克萨斯州亨茨维尔，主要向开展陆地、沼泽及深浅水区域勘探的地震数据采集承包商销售地球物理勘探及其他相关设备。公司主要运营两大业务板块，分别为设备租赁和设备制造，2011年10月还在匈牙利布达佩斯新设了一处物流与维修中心。
IMVT vs MIND — 直观对比
营收规模更大
MIND
是对方的1.2倍
$8.4M
营收增速更快
IMVT
高出160.7%
-20.0%
净利率更高
MIND
高出899.6%
-899.0%
自由现金流更多
MIND
多$60.6M
$-59.8M
损益表 — Q4 FY2024 vs Q3 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $8.4M | $9.7M |
| 净利润 | $-75.3M | $62.0K |
| 毛利率 | — | 46.6% |
| 营业利润率 | -896.2% | 8.0% |
| 净利率 | -899.0% | 0.6% |
| 营收同比 | 140.7% | -20.0% |
| 净利润同比 | -26.7% | -95.2% |
| 每股收益（稀释后） | $-0.50 | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收IMVTMIND
| Q4 25 | — | $9.7M | ||
| Q3 25 | — | $13.6M | ||
| Q2 25 | — | $7.9M | ||
| Q1 25 | — | $15.0M | ||
| Q4 24 | — | $12.1M | ||
| Q3 24 | — | $10.0M | ||
| Q2 24 | — | $9.7M | ||
| Q1 24 | $8.4M | $13.4M |
净利润IMVTMIND
| Q4 25 | — | $62.0K | ||
| Q3 25 | — | $1.9M | ||
| Q2 25 | — | $-970.0K | ||
| Q1 25 | — | $2.0M | ||
| Q4 24 | — | $1.3M | ||
| Q3 24 | — | $798.0K | ||
| Q2 24 | — | $954.0K | ||
| Q1 24 | $-75.3M | $1.4M |
毛利率IMVTMIND
| Q4 25 | — | 46.6% | ||
| Q3 25 | — | 50.4% | ||
| Q2 25 | — | 42.2% | ||
| Q1 25 | — | 43.5% | ||
| Q4 24 | — | 44.8% | ||
| Q3 24 | — | 47.6% | ||
| Q2 24 | — | 43.6% | ||
| Q1 24 | — | 46.7% |
营业利润率IMVTMIND
| Q4 25 | — | 8.0% | ||
| Q3 25 | — | 19.6% | ||
| Q2 25 | — | -8.3% | ||
| Q1 25 | — | 18.5% | ||
| Q4 24 | — | 15.5% | ||
| Q3 24 | — | 14.2% | ||
| Q2 24 | — | 7.5% | ||
| Q1 24 | -896.2% | 17.3% |
净利率IMVTMIND
| Q4 25 | — | 0.6% | ||
| Q3 25 | — | 14.2% | ||
| Q2 25 | — | -12.3% | ||
| Q1 25 | — | 13.5% | ||
| Q4 24 | — | 10.7% | ||
| Q3 24 | — | 8.0% | ||
| Q2 24 | — | 9.9% | ||
| Q1 24 | -899.0% | 10.8% |
每股收益（稀释后）IMVTMIND
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | $-0.50 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $635.4M | $19.4M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $617.8M | $39.9M |
| 总资产 | $666.4M | $47.3M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资IMVTMIND
| Q4 25 | — | $19.4M | ||
| Q3 25 | — | $7.8M | ||
| Q2 25 | — | $9.2M | ||
| Q1 25 | — | $5.3M | ||
| Q4 24 | — | $3.5M | ||
| Q3 24 | — | $1.9M | ||
| Q2 24 | — | $924.0K | ||
| Q1 24 | $635.4M | $5.3M |
股东权益IMVTMIND
| Q4 25 | — | $39.9M | ||
| Q3 25 | — | $28.8M | ||
| Q2 25 | — | $26.6M | ||
| Q1 25 | — | $27.3M | ||
| Q4 24 | — | $25.2M | ||
| Q3 24 | — | $24.5M | ||
| Q2 24 | — | $23.6M | ||
| Q1 24 | $617.8M | $22.6M |
总资产IMVTMIND
| Q4 25 | — | $47.3M | ||
| Q3 25 | — | $35.8M | ||
| Q2 25 | — | $36.2M | ||
| Q1 25 | — | $36.7M | ||
| Q4 24 | — | $36.1M | ||
| Q3 24 | — | $37.8M | ||
| Q2 24 | — | $34.9M | ||
| Q1 24 | $666.4M | $33.5M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-59.7M | $894.0K |
| 自由现金流经营现金流 - 资本支出 | $-59.8M | $801.0K |
| 自由现金流率自由现金流/营收 | -714.4% | 8.3% |
| 资本支出强度资本支出/营收 | 1.8% | 1.0% |
| 现金转化率经营现金流/净利润 | — | 14.42× |
| 过去12个月自由现金流最近4个季度 | $-214.6M | $5.1M |
8季度趋势，按日历期对齐
经营现金流IMVTMIND
| Q4 25 | — | $894.0K | ||
| Q3 25 | — | $-1.2M | ||
| Q2 25 | — | $4.1M | ||
| Q1 25 | — | $2.1M | ||
| Q4 24 | — | $2.3M | ||
| Q3 24 | — | $1.1M | ||
| Q2 24 | — | $-4.8M | ||
| Q1 24 | $-59.7M | $657.0K |
自由现金流IMVTMIND
| Q4 25 | — | $801.0K | ||
| Q3 25 | — | $-1.3M | ||
| Q2 25 | — | $3.8M | ||
| Q1 25 | — | $1.8M | ||
| Q4 24 | — | $2.2M | ||
| Q3 24 | — | $978.0K | ||
| Q2 24 | — | $-4.8M | ||
| Q1 24 | $-59.8M | $566.0K |
自由现金流率IMVTMIND
| Q4 25 | — | 8.3% | ||
| Q3 25 | — | -9.9% | ||
| Q2 25 | — | 48.5% | ||
| Q1 25 | — | 12.2% | ||
| Q4 24 | — | 18.3% | ||
| Q3 24 | — | 9.7% | ||
| Q2 24 | — | -49.8% | ||
| Q1 24 | -714.4% | 4.2% |
资本支出强度IMVTMIND
| Q4 25 | — | 1.0% | ||
| Q3 25 | — | 1.3% | ||
| Q2 25 | — | 3.0% | ||
| Q1 25 | — | 1.5% | ||
| Q4 24 | — | 0.6% | ||
| Q3 24 | — | 0.8% | ||
| Q2 24 | — | 0.7% | ||
| Q1 24 | 1.8% | 0.7% |
现金转化率IMVTMIND
| Q4 25 | — | 14.42× | ||
| Q3 25 | — | -0.60× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 1.01× | ||
| Q4 24 | — | 1.77× | ||
| Q3 24 | — | 1.33× | ||
| Q2 24 | — | -4.98× | ||
| Q1 24 | — | 0.46× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
